Connor, Clark & Lunn Investment Management (CC&L)
ETNB

Connor, Clark & Lunn Investment Management (CC&L)’s 89bio ETNB Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-108,441
Closed -$1.67M – 1426
2023
Q3 		$1.67M Sell
108,441
-103,617
-49% -$1.74M 0.01% 666
2023
Q2 		$4.02M Buy
212,058
+122,719
+137% +$2.16M 0.02% 438
2023
Q1 		$1.36M Buy
+89,339
New +$1.16M 0.01% 641
2022
Q4 		– Sell
-18,165
Closed -$105K – 1280
2022
Q3 		$105K Buy
+18,165
New +$79.8K ﹤0.01% 1038

Other funds holding ETNB

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s ETNB Position: Q4 2023 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of 89bio (ETNB) in Q4 2023, closing a stake of 108,441 shares — an estimated $1.67M sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in ETNB in Q3 2022 and held it in 4 quarters. The position peaked at $4.02M in Q2 2023. 153 funds tracked by Wall St. Rank hold ETNB as of Q4 2023.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining 89bio position as of Q4 2023 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 108,441 89bio shares in Q4 2023, an estimated $1.67M.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in 89bio in Q3 2022 and held it in 4 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s 89bio position peaked at $4.02M in Q2 2023.
  • 153 funds tracked by Wall St. Rank held 89bio as of Q4 2023.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q4 2023, filed 9 Feb 2024.